Reuters logo
BRIEF-Shanxi C&Y Pharmaceutical Group sees 2017 Q1 to Q3 net profit to decrease up to 20 pct
October 16, 2017 / 8:16 AM / a month ago

BRIEF-Shanxi C&Y Pharmaceutical Group sees 2017 Q1 to Q3 net profit to decrease up to 20 pct

Oct 16 (Reuters) - Shanxi C&Y Pharmaceutical Group Co Ltd :

* Sees net profit for 2017 Q1 to Q3 to decrease up to 20 percent, or to be 23.3 million yuan to 29.1 million yuan, compared to net profit of 2016 Q1 to Q3 (29.1 million yuan)

Source text in Chinese: goo.gl/q7tesA

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below